In vitro and in vivo evaluation of novel implantable collagen-chitosan- soybean phosphatidylcholine composite film for the sustained delivery of mitomycin C

Drug Development Research

Volumn 70, Issue 3, 2009, Pages 206-213

  Hou, Zhenqing ^a   Sun, Qian ^a   Wang, Qian ^a   Han, Jing ^a   Wang, Yuqian ^a   Zhang, Qiqing ^a  

^a XIAMEN UNIVERSITY   (China)

Author keywords

Chitosan; Drug delivery; Film; Implant; Mitomycin c

Indexed keywords

CHITOSAN; COLLAGEN; MITOMYCIN C; NANOPARTICLE; PHOSPHATIDYLCHOLINE; POLYLACTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; CANCER INHIBITION; CONTROLLED STUDY; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG IMPLANTATION; EMULSION; EVAPORATION; FEMALE; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; SOYBEAN; SUSTAINED DRUG RELEASE; TUMOR GROWTH; ULTRAVIOLET SPECTROSCOPY;

EID: 66249108929     PISSN: 02724391     EISSN: 10982299     Source Type: Journal    
DOI: 10.1002/ddr.20296     Document Type: Article

References (26)

1. Athanasiou K, Niederauer G, Agrawal C. 1996. Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/ polyglycolic acid copolymers. Biomaterials 17:93-102. (Pubitemid 26031365)
2. Banerjee T, Mitra S, Kumar SA, Kumar SR, Maitra A. 2002. Preparation, characterization, and biodistribution of ultrafine chitosan nanoparticles. Int J Pharm 243:93-105. (Pubitemid 35401293)
3. Dorta MJ, Oliva A, Amunguia O, Llabres M, Farina JB. 2002. Invivo release of fluoropyimidines from PLGA film implants. J Pharm Pharacol 54:757-763. (Pubitemid 34649462)
4. Elkharraz K, Faisant N, Guse C, Siepmann F, Arica-Yegin B, Oger JM, Gust R, Goepferich A, Benoit JP, Siepmann J. 2006. Paclitaxel-loaded microparticles and implants for the treatment of brain cancer: preparation and physicochemical characterization. Int J Pharm 314:127-136.
5. Emmanuel AH, Vessela V, Christine A, Micheline PM. 2005. In vitro and in vivo characterization of a novel biocompatible polymer- lipid implant system for the sustained delivery of paclitaxel. J Control Release 104:181-191.
6. Freese B, Sabel W, Saltzman M, During RL. 1989. Controlled release of dopamine from a polymeric brain implant: in vitro characterization. Exp Neurol 103:234-238. (Pubitemid 19076160)
7. Fu K, Pack D, Klibanov A, Langer R. 2000. Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres. Pharm Res 17:100-106. (Pubitemid 30121107)
8. Fulzele S, Satturwar P, Dorle A. 2003. Study of the biodegradation and in vivo biocompatibility of novel biomaterials. Eur J Pharm Sci 20:53-61. (Pubitemid 37103232)
9. Grant J, Blicker M, Piquette-Miller M, Allen C. 2005. Hybrid films from blends of chitosan and egg phosphatidylcholine for localized delivery of paclitaxel. J Pharm Sci 94:1512-1527. (Pubitemid 41168681)
10. Guminska M, Ignacak J, Wojcik E. 1996. In vitro inhibitory effect of chitosan and its degradation products on energy metabolism in Ehrlich ascites tumour cells (EAT). Pol J Pharmacol 48:495-501.
11. Gumusderelioglu M, Deniz G. 2002. Sustained release of mitomycin-C from poly (D,L-lactide)/poly(D,L-lactide-co-glycolide) films. J Biomater Sci Polymer Ed 11:1039-1050.
12. Hasegawa M, Yagi K, Iwakawa S, Hirai M. 2001. Chitosan induces apoptosis via caspase-3 activation in bladder tumor cells. Jpn J Cancer Res 92:459-466. (Pubitemid 32427783)
13. Hickey T, Kreutzer D, Brugess D, Moussy F. 2002. In vivo evaluation of a dexamethasone/PLGA microsphere system designed to suppress the inflammatory tissue response to implantable medical devices. J Biomed Mater Res 61:180-187.
14. Iwasaki Y, Sawada S, Nakabayashi N, Khang G, Lee HB, Ishihara K. 1999. The effect of the chemical structure of the phospholipid polymer on fibronectin adsorption and fibroblast adhesion on the gradient phospholipid surface. Biomaterials 20:2185-2191. (Pubitemid 29488668)
15. Jackson JK, Skinner KC, Burgess L, Sun T, Hunter WL, Burt HM. 2002. Paclitaxel-loaded crosslinked hyaluronic acid films for the prevention of postsurgical adhesions. Pharm Res 19:411-417. (Pubitemid 34408937)
16. Kumanohoso T, Natsugoe S, Shimada M, Aikou T, Nakamura K, Yamada K, Fukuzaki H. 1994. In vivo activity of bleomycin incorporated with biodegradable poly-DL-lactic acid and implanted in the mediastinum of dogs. J Surg Oncol 57:178-182.
17. Kumbar S, Soppimath K, Aminabhavi T. 2003. Synthesis and characterization of polyacrylamide grafted chitosan hydrogel microspheres for the controlled release of indomethacin. J Appl Polymer Sci 87:1525-1536. (Pubitemid 36103740)
18. Lawrence K, Fung W, Mark S. 1997. Polymeric implants for cancer chemotherapy. Adv Drug Deliv Rev 26:209-230. (Pubitemid 27289535)
19. Liang ZH, Zhou CR, Lin CP, Hong AH, Li GQ. 2006. Influence of chitosan, collagen, collagen/chitosan films on red blood cells [in Chinese]. Polymer Mater Sci Eng 22:161-164.
20. Nishi C, Nakajima N, Ikada Y. 2002. In vitro evaluation of cytotoxicity of diepoxy compounds used for biomaterial modification. J Biomed Mater Res 29:829-834.
21. Rauth AM, Mohindra JK, Tannock IF. 1983. Activity of mitomycin C for aerobic and hypoxic cells in vitro and in vivo. Cancer Res 43:4154-4158.
22. Rockwell S, Hughes CS. 1994. Effects of mitomycin C and porphyromycin on exponentially growing and plateau phase cultures. Cell Prolif 27:153-163. (Pubitemid 24078232)
23. Siegel SJ, Kahn JB, Metzger K, Winey KI, Wemer K, Dan N. 2006. Effect of drug type on the degradation rate of PLGA matrices. Eur J Pharm Biopharm 64:287-293. (Pubitemid 44585214)
24. Taylor M, Daniels A, Andriano K, Heller J. 1994. Six bioabsorbable polymers: in vitro acute toxicity of accumulated degradation products. J Appl Biomater 5:151-157.
25. Thacharodi D, Panduranga Rao K. 1995. Collagen-chitosan composite membranes for controlled release of propranolol hydrochloride. Int J Pharm 120:115-118.
26. Winternitz CI, Jackson JK, Oktaba AM, Burt HM. 1996. Development of a polymeric surgical paste formulation of taxol. Pharm Res 13:368-375. (Pubitemid 26114726)